+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Macular Degeneration"

From
Age-related Macular Degeneration Market 2024-2028 - Product Thumbnail Image

Age-related Macular Degeneration Market 2024-2028

  • Report
  • December 2023
  • 158 Pages
  • Global
From
From
From
From
From
UAE Ophthalmoscope Market, By Region, Competition, Forecast & Opportunities, 2019-2029F - Product Thumbnail Image

UAE Ophthalmoscope Market, By Region, Competition, Forecast & Opportunities, 2019-2029F

  • Report
  • October 2024
  • 88 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision. Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more